Guinea-Bissau: Controversial Infant Clinical Trial Allowed to Continue

In Guinea-Bissau, a controversial clinical trial on protecting newborns from hepatitis B has been permitted to proceed. Danish researchers plan to recruit 14,000 infants, withholding vaccination from half of them during the first six weeks, contrary to WHO guidelines. The project, partly funded by the United States, has sparked outrage, especially after Robert Francis Kennedy Jr., who regularly criticizes vaccine efficacy, praised the Danish researchers during an anti-vaccine conference.